tb-500+bpc-157 BPC-157 vs. TB-500: What Patients Should Know BPC-157 + TB-500 — 10

Blue Wave Compounds is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act

The amount of the drug component will be determined using the methodology for pricing the drug component of an episode of care at 410.67(d)(2)(i), which uses ASP data when available (with certain exceptions)

We stated in the CY 2025 PFS proposed rule (89 FR 61966) that should we pursue this option, we would explore using existing AMP reporting processes for the MDRP to operationalize any new AMP reporting requirement

Only sore arm

If exposure lasted longer than 12 hours, the medication should be discarded to avoid reduced effectiveness or safety concerns

No human clinical trial data quantifies the precise acceleration rate in humans, and the direct translation of the 30% to 50% figure from rodent models to human tendon repair remains unconfirmed by controlled clinical research